Can Antipsychotics Be the Reason for Developing Alzheimer's Disease in Schizophrenic Patients? : A Novel perspective

Dopamine antagonists, the standard drugs for treating schizophrenia, might contribute to inducing Alzheimer's disease in patients since dopaminergic dysregulation underlies both diseases. The observation represents a call for investigating the mechanisms by which antipsychotics influence neurodegeneration more thoroughly and to come up with improved options with fewer cognitive side effects.